Emmanuel Khalifa

1.2k total citations
15 papers, 321 citations indexed

About

Emmanuel Khalifa is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Emmanuel Khalifa has authored 15 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Emmanuel Khalifa's work include Cancer Genomics and Diagnostics (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Emmanuel Khalifa is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Emmanuel Khalifa collaborates with scholars based in France, United States and United Kingdom. Emmanuel Khalifa's co-authors include Antoîne Italiano, Carlo Lucchesi, Yec’han Laizet, Maxime Brunet, Christine Chomienne, Antoine Italiano, Simone Mathoulin‐Pélissier, Gaëlle Pérot, Laétitia Mayeur and Valérie Velasco and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Annals of Neurology.

In The Last Decade

Emmanuel Khalifa

15 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuel Khalifa France 7 163 112 69 56 55 15 321
Vanessa Vanspauwen Belgium 9 229 1.4× 96 0.9× 28 0.4× 40 0.7× 82 1.5× 13 333
Mariola Iliszko Poland 12 189 1.2× 121 1.1× 88 1.3× 44 0.8× 117 2.1× 27 363
Alfredo Romero-Rojas Colombia 10 78 0.5× 47 0.4× 97 1.4× 39 0.7× 50 0.9× 50 333
Atsuko Saito Japan 12 139 0.9× 98 0.9× 83 1.2× 27 0.5× 81 1.5× 18 409
Ken-ichi Kawaguchi Japan 14 344 2.1× 180 1.6× 104 1.5× 41 0.7× 184 3.3× 20 573
Stefania Kokkali Greece 11 89 0.5× 100 0.9× 62 0.9× 56 1.0× 48 0.9× 38 251
J. Frans Graadt van Roggen Netherlands 6 174 1.1× 91 0.8× 77 1.1× 48 0.9× 49 0.9× 7 310
Qihan You China 10 170 1.0× 146 1.3× 106 1.5× 43 0.8× 45 0.8× 27 323
Omar Jaber Jordan 9 143 0.9× 73 0.7× 46 0.7× 23 0.4× 78 1.4× 28 307
Suk Wai Lam Netherlands 11 216 1.3× 76 0.7× 29 0.4× 53 0.9× 54 1.0× 20 317

Countries citing papers authored by Emmanuel Khalifa

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Khalifa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Khalifa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Khalifa more than expected).

Fields of papers citing papers by Emmanuel Khalifa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Khalifa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Khalifa. The network helps show where Emmanuel Khalifa may publish in the future.

Co-authorship network of co-authors of Emmanuel Khalifa

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Khalifa. A scholar is included among the top collaborators of Emmanuel Khalifa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Khalifa. Emmanuel Khalifa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Italiano, Antoine, Isabelle Soubeyran, Emmanuel Khalifa, et al.. (2024). Extensive molecular profiling of KRAS wild-type as compared to KRAS mutated pancreatic ductal adenocarcinoma on 318 patients. European Journal of Cancer. 216. 115197–115197. 1 indexed citations
2.
Debien, Véronique, Alexandre Moreau, Florent Peyraud, et al.. (2024). 84P Advancing precision oncology: Integrating immune landscape and genomics for tailored therapy in metastatic cancer patients. Annals of Oncology. 35. S248–S248. 1 indexed citations
3.
Italiano, Antoîne, Amandine Crombé, Isabelle Soubeyran, et al.. (2024). Are DNA Repair Gene Alterations Associated With the Response to Platinum-Based Regimen and Immune Checkpoint Inhibitors in Patients With Solid Tumors?. The Oncologist. 29(5). 452–455. 1 indexed citations
4.
Lena, Jonathan, Antoîne Italiano, Isabelle Soubeyran, et al.. (2023). 1634P Extensive molecular profiling of KRAS wild-type versus KRAS mutant pancreatic ductal adenocarcinoma on 233 patients. Annals of Oncology. 34. S904–S904. 2 indexed citations
5.
Velasco, Valérie, F. Kommoss, Esther Oliva, et al.. (2023). Pan‐TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls. Histopathology. 84(3). 451–462. 5 indexed citations
7.
Brunet, Maxime, Emmanuel Khalifa, & Antoîne Italiano. (2019). Enabling Precision Medicine for Rare Head and Neck Tumors: The Example of BRAF/MEK Targeting in Patients With Metastatic Ameloblastoma. Frontiers in Oncology. 9. 1204–1204. 33 indexed citations
8.
Truntzer, Caroline, Romain Boidot, Emmanuel Khalifa, et al.. (2019). Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations. Modern Pathology. 33(6). 1041–1055. 44 indexed citations
10.
Lucchesi, Carlo, Emmanuel Khalifa, Yec’han Laizet, et al.. (2018). Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas. JAMA Oncology. 4(10). 1398–1398. 69 indexed citations
11.
Leroy, Laura, Julien Adam, Véronique Brouste, et al.. (2017). IDO-1 and PD-L1 predict response to immunotherapy in advanced non small cell lung cancer: An NGS and multiplex IHC analysis. Annals of Oncology. 28. v417–v417. 2 indexed citations
12.
Grellety, Thomas, Carlo Lucchesi, Isabelle Hostein, et al.. (2017). High-depth sequencing of paired primary and metastatic tumours: Implications for personalised medicine. European Journal of Cancer. 84. 250–256. 6 indexed citations
13.
Italiano, Antoîne, Emmanuel Khalifa, Yec’han Laizet, et al.. (2017). Genetic landscape of soft-tissue sarcomas: Moving toward personalized medicine.. Journal of Clinical Oncology. 35(15_suppl). 11002–11002. 10 indexed citations
14.
Bourdeau, Isabelle, Solange Grunenwald, Nelly Burnichon, et al.. (2016). A SDHC Founder Mutation Causes Paragangliomas (PGLs) in the French Canadians: New Insights on the SDHC-Related PGL. The Journal of Clinical Endocrinology & Metabolism. 101(12). 4710–4718. 30 indexed citations
15.
Funalot, Benoît, Piotr Topilko, Abdelaziz Sefiani, et al.. (2012). Homozygous deletion of an EGR2 enhancer in congenital amyelinating neuropathy. Annals of Neurology. 71(5). 719–723. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026